Biocon Limited vs Rhythm Pharmaceuticals, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Biocon Limited is the larger company by market value: $6.4 B against $6.0 B for Rhythm Pharmaceuticals, Inc., 1.1 times as much (market caps of Nov 20, 2026 for Biocon Limited and Oct 15, 2026 for Rhythm Pharmaceuticals, Inc.).
- Biocon Limited had more revenue: $1.8 B in the year to March 2026 against $190 M for Rhythm Pharmaceuticals, Inc. in the year to December 2025.
- Biocon Limited made a net profit of $42 M, while Rhythm Pharmaceuticals, Inc. made a net loss of $197 M.
- Biocon Limited keeps more of each dollar of sales: a net margin of 2.3% against -103.6% for Rhythm Pharmaceuticals, Inc.
- Biocon Limited employs more people: 12,000 against 414 at Rhythm Pharmaceuticals, Inc. Each employee brings in about $150,988 of revenue at Biocon Limited and $458,357 at Rhythm Pharmaceuticals, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Biocon Limited BIOCON.BO · #2,992 in the world | Rhythm Pharmaceuticals, Inc. RYTM · #3,141 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇳 India | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 1978 | 2008 |
| Size | ||
| Market cap | $6.4 B | $6.0 B |
| Revenue | $1.8 B | $190 M |
| Net income | $42 M▲ best | $-197 M |
| Employees | 12,000 | 414 |
| Valuation | ||
| P/E ratio | 154× | — |
| Price to sales | 3.5× | 21.4× |
| Price to book | 1.6× | 43.2× |
| Free cash flow yield | — | -1.9% |
| Profitability | ||
| Gross margin | — | 89.7% |
| Operating margin | — | -101.2% |
| Net margin | — | -103.6% |
| Return on equity | — | -244.4% |
| Growth | ||
| Revenue growth | — | 45.8% |
| Revenue growth, 3 years a year | — | 100.2% |
| Financial strength | ||
| Debt to equity | — | 0.7× |
| Cash | ||
| Free cash flow margin | — | -61.5% |
| Strength scores | ||
| Piotroski F-score | — | 6 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Nov 2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Biocon Limited or Rhythm Pharmaceuticals, Inc.?
Biocon Limited is the larger company by market value: $6.4 B against $6.0 B for Rhythm Pharmaceuticals, Inc., 1.1 times as much (market caps of Nov 20, 2026 for Biocon Limited and Oct 15, 2026 for Rhythm Pharmaceuticals, Inc.).
Which makes more money, Biocon Limited or Rhythm Pharmaceuticals, Inc.?
Biocon Limited had more revenue: $1.8 B in the year to March 2026 against $190 M for Rhythm Pharmaceuticals, Inc. in the year to December 2025. Biocon Limited made a net profit of $42 M, while Rhythm Pharmaceuticals, Inc. made a net loss of $197 M.
Which is more profitable, Biocon Limited or Rhythm Pharmaceuticals, Inc.?
Biocon Limited keeps more of each dollar of sales: a net margin of 2.3% against -103.6% for Rhythm Pharmaceuticals, Inc.
Which has more employees, Biocon Limited or Rhythm Pharmaceuticals, Inc.?
Biocon Limited employs more people: 12,000 against 414 at Rhythm Pharmaceuticals, Inc. Each employee brings in about $150,988 of revenue at Biocon Limited and $458,357 at Rhythm Pharmaceuticals, Inc.